Long‐Term Treatment With TNF‐Alpha Inhibitors Improves Bone Mineral Density But Not Vertebral Fracture Progression in Ankylosing Spondylitis (2024)

Article Navigation

Volume 34 Issue 6 1 June 2019
  • < Previous
  • Next >

Journal Article

Get access

,

Kimberley Johanna Beek

Department of Rheumatology Amsterdam Rheumatology and Immunology Centre Amsterdam UMC Amsterdam The Netherlands

Search for other works by this author on:

Oxford Academic

,

Tamara Rusman

Department of Rheumatology Amsterdam Rheumatology and Immunology Centre Amsterdam UMC Amsterdam The Netherlands

Search for other works by this author on:

Oxford Academic

,

Maria Alida Cornelia van der Weijden

Department of Rheumatology Groene hart ziekenhuis Gouda The Netherlands

Search for other works by this author on:

Oxford Academic

,

Willem Frederik Lems

Department of Rheumatology Amsterdam Rheumatology and Immunology Centre, Reade Amsterdam The Netherlands

Department of Rheumatology Amsterdam Rheumatology and Immunology Centre Amsterdam UMC Amsterdam The Netherlands

Search for other works by this author on:

Oxford Academic

,

Johannes Christiaan van Denderen

Department of Rheumatology Amsterdam Rheumatology and Immunology Centre, Reade Amsterdam The Netherlands

Search for other works by this author on:

Oxford Academic

,

Maria Konsta

Department of Rheumatology Veterans Administration Hospital (NIMTS) Athens Greece

Department of Rheumatology Amsterdam Rheumatology and Immunology Centre Amsterdam UMC Amsterdam The Netherlands

Search for other works by this author on:

Oxford Academic

, ,

Michael Twahier Nurmohamed

Department of Rheumatology Amsterdam Rheumatology and Immunology Centre, Reade Amsterdam The Netherlands

Department of Rheumatology Amsterdam Rheumatology and Immunology Centre Amsterdam UMC Amsterdam The Netherlands

Search for other works by this author on:

Oxford Academic

Irene Eva van der Horst‐Bruinsma

Department of Rheumatology Amsterdam Rheumatology and Immunology Centre Amsterdam UMC Amsterdam The Netherlands

Address correspondence to: Prof. dr. I. E. van der Horst‐Bruinsma, VU University Medical Center, Room 3A‐64, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands. E‐mail: ie.vanderhorst@vumc.nl

Search for other works by this author on:

Oxford Academic

Journal of Bone and Mineral Research, Volume 34, Issue 6, 1 June 2019, Pages 1041–1048, https://doi.org/10.1002/jbmr.3684

Published:

28 January 2019

Article history

Received:

17 May 2018

Revision received:

15 January 2019

Accepted:

19 January 2019

Published:

28 January 2019

  • Views
    • Article contents
    • Figures & tables
    • Video
    • Audio
    • Supplementary Data
  • Cite

    Cite

    Kimberley Johanna Beek, Tamara Rusman, Maria Alida Cornelia van der Weijden, Willem Frederik Lems, Johannes Christiaan van Denderen, Maria Konsta, Ingrid Visman, Michael Twahier Nurmohamed, Irene Eva van der Horst‐Bruinsma, Long‐Term Treatment With TNF‐Alpha Inhibitors Improves Bone Mineral Density But Not Vertebral Fracture Progression in Ankylosing Spondylitis, Journal of Bone and Mineral Research, Volume 34, Issue 6, 1 June 2019, Pages 1041–1048, https://doi.org/10.1002/jbmr.3684

    Close

Search

Close

Search

Advanced Search

Search Menu

ABSTRACT

The aim of this cohort study was to evaluate the long‐term effects of TNF inhibitors (TNFis) on BMD and the incidence of vertebral fractures (VFxs) in patients with ankylosing spondylitis (AS). Consecutive patients with active AS with TNFi treatment duration up to 4 years with available DXA scans and spine X‐rays were included. BMD (classified according to the WHO criteria for osteoporosis) of the hip and lumbar spine, the VFx (classified as a Genant score text-decoration:underline1/text-decoration:underline20% height loss), and radiological progression (modified stoke ankylosing spondylitis spinal score [mSASSS]) scores were obtained at baseline and at 4 years of TNFi treatment. Overall, 135 AS patients were included. At baseline, 40.1% of patients had low BMD of the hip and 40.2% of the lumbar spine. This decreased to 38.1% (p = 0.03) with low hip BMD and 25.3% (p < 0.001) of the lumbar spine BMD after 4 years of TNFi treatment. VFxs were present at baseline in 11.1% of the 131 patients, which increased to 19.6% after 4 years of TNFi treatment. A Genant score ≥2, was found at baseline in 3 out of 14 VFx (21.4%) patients, which increased to 7 out of 27 VFx (25.9%) patients after 4 years. All disease activity parameters—the ankylosing spondylitis disease activity scale, the C‐reactive protein, the erythrocyte sedimentation rate, and the bath ankylosing spondylitis disease activity index—decreased significantly (p < 0.001). The mean radiological progression (n = 80) increased significantly from a median mSASSS of 4.0 (1.5 to 16.0) at baseline to 6.5 (2.1 to 22.9) after 4 years of TNFi treatment (p < 0.001). Despite the improvement in BMD and the decrease in disease activity, we still found new VFxs, an increase in severity in the number and grade of VFxs, and radiographic progression during 4 years of treatment with TNFis in AS patients with long disease duration. © 2019 American Society for Bone and Mineral Research.

ANKYLOSING SPONDYLITIS, BONE MINERAL DENSITY, VERTEBRAL FRACTURES, RADIOLOGICAL DAMAGE, TNF ALPHA INHIBITORS

© 2019 American Society for Bone and Mineral Research

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

Issue Section:

Original Articles

You do not currently have access to this article.

Download all slides

Sign in

Get help with access

Personal account

  • Sign in with email/username & password
  • Get email alerts
  • Save searches
  • Purchase content
  • Activate your purchase/trial code
  • Add your ORCID iD

Sign in Register

Institutional access

    Sign in through your institution

    Sign in through your institution

  1. Sign in with a library card
  2. Sign in with username/password
  3. Recommend to your librarian

Institutional account management

Sign in as administrator

Get help with access

Institutional access

Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:

IP based access

Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.

Sign in through your institution

Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.

  1. Click Sign in through your institution.
  2. Select your institution from the list provided, which will take you to your institution's website to sign in.
  3. When on the institution site, please use the credentials provided by your institution. Do not use an Oxford Academic personal account.
  4. Following successful sign in, you will be returned to Oxford Academic.

If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.

Sign in with a library card

Enter your library card number to sign in. If you cannot sign in, please contact your librarian.

Society Members

Society member access to a journal is achieved in one of the following ways:

Sign in through society site

Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:

  1. Click Sign in through society site.
  2. When on the society site, please use the credentials provided by that society. Do not use an Oxford Academic personal account.
  3. Following successful sign in, you will be returned to Oxford Academic.

If you do not have a society account or have forgotten your username or password, please contact your society.

Sign in using a personal account

Some societies use Oxford Academic personal accounts to provide access to their members. See below.

Personal account

A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.

Some societies use Oxford Academic personal accounts to provide access to their members.

Viewing your signed in accounts

Click the account icon in the top right to:

  • View your signed in personal account and access account management features.
  • View the institutional accounts that are providing access.

Signed in but can't access content

Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.

Institutional account management

For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.

Purchase

Subscription prices and ordering for this journal

Purchasing options for books and journals across Oxford Academic

Short-term Access

To purchase short-term access, please sign in to your personal account above.

Don't already have a personal account? Register

Long‐Term Treatment With TNF‐Alpha Inhibitors Improves Bone Mineral Density But Not Vertebral Fracture Progression in Ankylosing Spondylitis - 24 Hours access

EUR €46.00

GBP £40.00

USD $49.00

Rental

Long‐Term Treatment With TNF‐Alpha Inhibitors Improves Bone Mineral Density But Not Vertebral Fracture Progression in Ankylosing Spondylitis (5)

This article is also available for rental through DeepDyve.

Advertisem*nt

Citations

Views

64

Altmetric

More metrics information

Metrics

Total Views 64

48 Pageviews

16 PDF Downloads

Since 2/1/2024

Month: Total Views:
February 2024 21
March 2024 11
April 2024 14
May 2024 18

Citations

Powered by Dimensions

26 Web of Science

Altmetrics

×

Email alerts

Article activity alert

Advance article alerts

New issue alert

Receive exclusive offers and updates from Oxford Academic

Email alerts

Advance article alerts

New issue alert

Receive exclusive offers and updates from Oxford Academic

Related articles in

Citing articles via

Google Scholar

  • Latest

  • Most Read

  • Most Cited

The role of mechanotransduction in tendon
Comparative effectiveness of Denosumab vs alendronate among postmenopausal women with osteoporosis
Genetic predisposition to bone mineral density and their health conditions in East Asians
The lack of EphB3 receptor prevents bone loss in mouse models of osteoporosis
Effect of Abdominal Tissue Thickness on Trabecular Bone Score and Fracture Risk in Adults With Diabetes: The Manitoba BMD Registry

More from Oxford Academic

Clinical Medicine

Endocrinology and Diabetes

Medicine and Health

Neuroscience

Science and Mathematics

Books

Journals

Advertisem*nt

Long‐Term Treatment With TNF‐Alpha Inhibitors Improves Bone Mineral Density But Not Vertebral Fracture Progression in Ankylosing Spondylitis (2024)
Top Articles
Latest Posts
Article information

Author: Kerri Lueilwitz

Last Updated:

Views: 5850

Rating: 4.7 / 5 (47 voted)

Reviews: 94% of readers found this page helpful

Author information

Name: Kerri Lueilwitz

Birthday: 1992-10-31

Address: Suite 878 3699 Chantelle Roads, Colebury, NC 68599

Phone: +6111989609516

Job: Chief Farming Manager

Hobby: Mycology, Stone skipping, Dowsing, Whittling, Taxidermy, Sand art, Roller skating

Introduction: My name is Kerri Lueilwitz, I am a courageous, gentle, quaint, thankful, outstanding, brave, vast person who loves writing and wants to share my knowledge and understanding with you.